E-TH-related drugs and human experimental anxietyZUARDI, A. W.Neuroscience and biobehavioral reviews. 1990, Vol 14, Num 4, pp 507-510, issn 0149-7634, 4 p.Conference Paper

Pharmacological interaction of the effects of △⁹-trans-tetrahydrocannabinol and cannabidiol on serum corticosterone levels in ratsZUARDI, A. W; TEIXEIRA, N. A; KARNIOL, I. C et al.Archives internationales de pharmacodynamie et de thérapie. 1984, Vol 269, Num 1, pp 12-19, issn 0003-9780Article

Reliability, validity and factorial dimensions of the Interactive Observation Scale for Psychiatric InpatientsZUARDI, A. W; LOUREIRO, S. R; RODRIGUES, C. R. C et al.Acta psychiatrica Scandinavica. 1995, Vol 91, Num 4, pp 247-251, issn 0001-690XArticle

Effect of cannabidiol on plasma prolactin, growth hormone and cortisol in human volunteersZUARDI, A. W; GUIMARAES, F. S; MOREIRA, A. C et al.Brazilian journal of medical and biological research. 1993, Vol 26, Num 2, pp 213-217, issn 0100-879XArticle

Effects of cannabidiol in animal models predictive of antipsychotic acitivityZUARDI, A. W; ANTUNES RODRIGUES, J; CUNHA, J. M et al.Psychopharmacologia. 1991, Vol 104, Num 2, pp 260-264, issn 0033-3158Article

Cannabidiol for the treatment of cannabis withdrawal syndrome: a case reportCRIPPA, J. A. S; HALLAK, J. E. C; MACHADO-DE-SOUSA, J. P et al.Journal of clinical pharmacy and therapeutics (Print). 2013, Vol 38, Num 2, pp 162-164, issn 0269-4727, 3 p.Article

Cannabidiol for the treatment of psychosis in Parkinson's diseaseZUARDI, A. W; CRIPPA, J. A. S; HALLAK, J. E. C et al.Journal of psychopharmacology (Oxford). 2009, Vol 23, Num 8, pp 979-983, issn 0269-8811, 5 p.Article

Social anxiety disorder: what are we losing with the current diagnostic criteria?FILHO, A. S; HETEM, L. A. B; CRIPPA, J. A. S et al.Acta psychiatrica scandinavica. 2010, Vol 121, Num 3, pp 216-226, issn 0001-690X, 11 p.Article

Cannabidiol was ineffective for manic episode of bipolar affective disorderZUARDI, A. W; CRIPPA, Jas; DURSUN, S. M et al.Journal of psychopharmacology (Oxford). 2010, Vol 24, Num 1, pp 135-137, issn 0269-8811, 3 p.Article

Effect of d-fenfluramine on human experimental anxietyHETEM, L. A. B; DE SOUZA, C. J; GUIMARAES, F. S et al.Psychopharmacologia. 1996, Vol 127, Num 3, pp 276-282, issn 0033-3158Article

Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson's disease patients: a case seriesCHAGAS, M. H. N; ECKELI, A. L; TUMAS, V et al.Journal of clinical pharmacy and therapeutics (Print). 2014, Vol 39, Num 5, pp 564-566, issn 0269-4727, 3 p.Article

Antianxiety effect of cannabidiol in the elevated plus-mazeGUIMARAES, F. S; CHIARETTI, T. M; GRAEFF, F. G et al.Psychopharmacology. 1990, Vol 100, Num 4, pp 558-559, issn 0142-8411Article

ANTIPSYCHOTIC EFFECT OF CANNABIDIOLZUARDI, A. W; MORAIS, S. L; GUIMARAES, F. S et al.The Journal of clinical psychiatry. 1995, Vol 56, Num 10, pp 485-486, issn 0160-6689, 2 p.Conference Paper

D-fenfluramine reduces anxiety induced by simulated public speakingHETEM, L. A. B; DE-SOUZA, C. J; GUIMARAES, F. S et al.Brazilian journal of medical and biological research. 1993, Vol 26, Num 9, pp 971-974, issn 0100-879XArticle

Cortical thinning of the right anterior cingulate cortex in spider phobia: A magnetic resonance imaging and spectroscopy studyLINARES, I. M. P; JACKOWSKI, A. P; COIMBRA, N. C et al.Brain research. 2014, Vol 1576, pp 35-42, issn 0006-8993, 8 p.Article

A structured interview guide increases Brief Psychiatric Rating Scale reliability in raters with low clinical experienceCRIPPA, J. A. S; SANCHES, R. F; HALLAK, J. E. C et al.Acta psychiatrica Scandinavica. 2001, Vol 103, Num 6, pp 465-470, issn 0001-690XArticle

Effetc of metergoline on human anxietyGRAEFF, F. G; ZUARDI, A. W; GIGLIO, J. S et al.Psychopharmacologia. 1985, Vol 86, Num 3, pp 334-338, issn 0033-3158Article

Cannabis affects people differently: inter-subject variation in the psychotogenic effects of Δ⁹-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteersATAKAN, Z; BHATTACHARYYA, S; ZUARDI, A. W et al.Psychological medicine (Print). 2013, Vol 43, Num 6, pp 1255-1267, issn 0033-2917, 13 p.Article

Effects of ipsapirone and cannabidiol on human experimental anxietyZUARDI, A. W; COSME, R. A; GRAEFF, F. G et al.Journal of psychopharmacology (Oxford). 1993, Vol 7, Num 1, pp 82-88, issn 0269-8811Article

Double-blind comparison between two forms of haloperidol: an oral preparation and a new depot decanoate in the maintenance of schizophrenic inpatientsZUARDI, A. W; GIAMPIETRO, A. C; KARNIOL, I. G et al.Current therapeutic research. 1983, Vol 34, Num 2, pp 253-261, issn 0011-393XArticle